Related Experiment Video

Updated: Jan 30, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

10.7K

Giant Purulent Pericarditis with Cardiac Tamponade Due to Streptococcus intermedius Rapidly Progressing to

Elif T Tigen1, Ibrahim Sari2, Koray Ak3

  • 1Department of Infectious Diseases, School of Medicine, Marmara University, Istanbul, Turkey.

Echocardiography (Mount Kisco, N.Y.)
|March 5, 2015
PubMed

Insights

Purulent pericardial effusion is a rare but serious condition. Early diagnosis and treatment, including pericardiocentesis and antibiotics, are crucial for successful outcomes in patients with Streptococcus intermedius infections.

Area of Science:

  • Medicine
  • Infectious Diseases
  • Cardiology

Background:

  • Purulent pericardial effusion is a rare, life-threatening condition.
  • It often arises from nearby bacterial infections or bloodstream dissemination in immunocompromised individuals.
  • Clinical signs can be nonspecific, leading to diagnostic delays.

Observation:

  • A case of giant purulent pericardial effusion caused by Streptococcus intermedius is presented.
  • The patient had a history of bronchiectasis and pneumonia.
  • The effusion was successfully managed using a parasternal pericardiocentesis, antibiotics, and pericardiectomy.

Findings:

  • Streptococcus intermedius can cause severe purulent pericardial effusion.
  • A high index of suspicion is vital for prompt diagnosis.
  • Multimodal treatment including drainage, antibiotics, and surgery can be effective.

Implications:

  • This case highlights the importance of considering purulent pericardial effusion in patients with relevant risk factors.
  • Successful management strategies for this rare condition are demonstrated.
  • Further research into optimal diagnostic and therapeutic approaches for purulent pericardial effusion is warranted.
Keywords:
Streptococcus intermediusconstrictive pericarditisgiant purulent pericarditispericardial effusiontamponade

More Related Videos

Assessment of Cardiac Morphological and Functional Changes in Mouse Model of Transverse Aortic Constriction by Echocardiographic Imaging09:05

Assessment of Cardiac Morphological and Functional Changes in Mouse Model of Transverse Aortic Constriction by Echocardiographic Imaging

Published on: June 21, 2016

19.0K
Ascending Aortic Constriction in Rats for Creation of Pressure Overload Cardiac Hypertrophy Model10:18

Ascending Aortic Constriction in Rats for Creation of Pressure Overload Cardiac Hypertrophy Model

Published on: June 29, 2014

17.6K

Related Concept Videos

Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
361
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
349
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
321
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
389
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.8K